Patents by Inventor Jiangli Song

Jiangli Song has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for inhibition of cathepsins
    Patent number: 9873668
    Abstract: This invention is directed to compound of Formula I and methods of using these compounds in the treatment of conditions in which modulation of a cathepsin, particularly cathepsin K or cathepsin L, will be therapeutically useful.
    Type: Grant
    Filed: August 31, 2016
    Date of Patent: January 23, 2018
    Assignees: Mateon Therapeutics, Inc., Baylor University
    Inventors: David J. Chaplin, Kishore Kumar Gaddale Devanna, Erica Parker, Kevin G. Pinney, Jiangli Song, Mary Lynn Trawick
  • COMPOSITIONS AND METHODS FOR INHIBITION OF CATHEPSINS
    Publication number: 20160368869
    Abstract: This invention is directed to compound of Formula I and methods of using these compounds in the treatment of conditions in which modulation of a cathepsin, particularly cathepsin K or cathepsin L, will be therapeutically useful.
    Type: Application
    Filed: August 31, 2016
    Publication date: December 22, 2016
    Inventors: David J. Chaplin, Kishore Kumar Gaddale Devanna, Erica Parker, Kevin G. Pinney, Jiangli Song, Mary Lynn Trawick
  • Compositions and methods for inhibition of cathepsins
    Patent number: 9458103
    Abstract: This invention is directed to compound of Formula I and methods of using these compounds in the treatment of conditions in which modulation of a cathepsin, particularly cathepsin K or cathepsin L, will be therapeutically useful.
    Type: Grant
    Filed: October 2, 2014
    Date of Patent: October 4, 2016
    Assignees: Mateon Therapeutics, Inc., Baylor University
    Inventors: David J. Chaplin, Kishore Kumar Gaddale Devanna, Erica Parker, Kevin G. Pinney, Jiangli Song, Mary L. Trawick
  • Compositions and Methods for Inhibition of Cathepsins
    Publication number: 20150031915
    Abstract: This invention is directed to compound of Formula I and methods of using these compounds in the treatment of conditions in which modulation of a cathepsin, particularly cathepsin K or cathepsin L, will be therapeutically useful.
    Type: Application
    Filed: October 2, 2014
    Publication date: January 29, 2015
    Inventors: David J. Chaplin, Kishore Kumar Gaddale Devanna, Erica Parker, Kevin G. Pinney, Jiangli Song, Mary L. Trawick
  • Compositions and methods for inhibition of cathepsins
    Patent number: 8877967
    Abstract: This invention is directed to compound of Formula I and methods of using these compounds in the treatment of conditions in which modulation of a cathepsin, particularly cathepsin K or cathepsin L, will be therapeutically useful.
    Type: Grant
    Filed: March 5, 2013
    Date of Patent: November 4, 2014
    Assignees: OXiGENE, Inc., Baylor University
    Inventors: David J. Chaplin, Kishore Kumar Gaddale Devanna, Erica Parker, Kevin G. Pinney, Jiangli Song, Mary Lynn Trawick
  • Compositions and Methods for Inhibition of Cathepsins
    Publication number: 20130296605
    Abstract: This invention is directed to compound of Formula I and methods of using these compounds in the treatment of conditions in which modulation of a cathepsin, particularly cathepsin K or cathepsin L, will be therapeutically useful.
    Type: Application
    Filed: March 5, 2013
    Publication date: November 7, 2013
    Inventors: David J. Chaplin, Kishore Kumar Gaddale Devanna, Erica Parker, Kevin G. Pinney, Jiangli Song, Mary L. Trawick